세계의 3D 세포배양 시장 규모 : 유형별, 용도별, 최종사용자별, 지역별, 범위 및 예측

3D Cell Culture Market Size And Forecast

3D Cell Culture Market size was valued at USD 1.88 Billion in 2022 and is projected to reach USD 4.30 Billion in 2030 , at a CAGR of 10.87% from 2023 to 2030. Technological advancements in this segment, a growing emphasis on developing alternatives to animal testing, rising incidences of chronic diseases, and new product launches are expected to drive the 3D Cell Culture Market over the forecast years. The Global 3D Cell Culture Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global 3D Cell Culture Market Definition

3D cell culture is an artificially-created environment. A three-dimensional cell culture environment allows biological cells to interact with their surroundings in all three dimensions. In terms of cellular characteristics and behavior, cells grown in 3D cell culture exhibit similar properties to cells found in living organisms. In an in vivo condition, this technique allows cells to grow in their natural environment. In contrast to 2D environments, 3D cell culture enables cells to grow in all directions in an artificially created environment.

Biological cells are free to grow and interact with their surroundings in all three dimensions in this environment. Bioreactors and small capsules are frequently used to grow these three-dimensional environments in which cells can grow. 3D cell culture differentiates and migrates from normal cells by reacting to their three-dimensional surroundings. The enhanced utility of the cell aids in tissue maturation and organization. This method is commonly used in pharmaceutical and biotechnology companies, as well as academic institutions and research labs.

3D cultures are commonly used during research that requires in vivo model systems to study the effects of a foreign substance on bodily tissues and organs because they can precisely recreate the normal morphology and microarchitecture of organs. Moreover, due to the biomimetic tissue constructions used to produce 3D organotypic structures, a substantial number of research entities adopted 3-dimensional cell culture techniques. Furthermore, a novel approach to conventional methods for treating Covid-19, cancer, and other clinical illnesses has emerged: the use of 3D tissue-engineered models.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global 3D Cell Culture Market Overview

Rising public awareness of oncological diseases such as lung cancer and skin cancer, as well as the appealing benefits of 3D cell culture such as high strength and low prices, are among the factors expected to propel the expansion of the 3D Cell Culture Market. Moreover, its rising use in drug development and active government financial support for cancer research and advanced technologies as well as new product launches are anticipated to propel the 3D Cell Culture Market. In addition, the growing emphasis on developing alternatives to animal testing and growing market awareness is anticipated to drive the market. The availability of funding for research as well as the increasing incidence of chronic illnesses is predicted to fuel the market growth during the forecast years.

Furthermore, R&D efforts for drug discovery, innovation, and screening, as well as a preference for the use of 3D Cell culture in cancer research, are expected to propel market growth. Similarly, an increase in demand for organ transplantation is projected to augment the 3D Cell Culture Market growth. Cells grown on low-growth-factor scaffolds cannot be implanted in humans. This emphasises the need for materials that provide both natural ECM functionality and the ability to specify biological and material properties. Scaffolds made of synthetic materials, including such synthetic peptides, are anticipated to address this hindrance, however, lack of consistency continues to be a significant market problem until their initiation.

Moreover, excessive technology costs and a scarcity of skilled professionals are also anticipated to hamper market growth. Furthermore, Due to the COVID-19 pandemic, 3D cell culture is facing serious new difficulties in balancing the demand and availability of 3D cell culture components. Increasing inventions such as advanced treatments and diagnoses in neuromuscular disease are anticipated to provide abundant growth opportunities for the global 3D Cell Culture Market during the analysis timeframe. Moreover, advancements in 3D cell culture for replicating the entire spinal locomotion circuit are expected to grow the market. The rise in scientific research for developing novel therapies against COVID-19 represents a significant opportunity for market growth.

Market Attractiveness

The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Global 3D Cell Culture Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.

Porter's Five Forces

The image provided would further help to get information about Porter's five forces framework providing a blueprint for understanding the behavior of competitors and a player's strategic positioning in the respective industry. Porter's five forces model can be used to assess the competitive landscape in the Global 3D Cell Culture Market, gauge the attractiveness of a certain sector, and assess investment possibilities.

Global 3D Cell Culture Market Segmentation Analysis

The Global 3D Cell Culture Market is segmented on the basis of Type, Application, End Users, And Geography.

3D Cell Culture Market, By Type

3D Bioreactors

• Scaffold-Based Platform
• Scaffold-Free Platform
• Other
• To Get Summarized Market Report By Type:-

Based on Type, the market is segmented into 3D Bioreactors, Scaffold-Based Platform, Scaffold-Free Platform, and Other. 3D Bioreactors accounted for the largest market share in 2021, and is projected to grow at the highest CAGR of 20.03% during the forecast period. The bioreactor is composed of many independent, autoclavable polycarbonate chambers. The chambers are interchangeable and have been particularly designed to take advantage of 3D Insert scaffolds in sizes ranging from 24-well to 12-well to 6-well. Cell culture media is perfused through the open porous structure of scaffolds using a peristaltic pump. The entire unit is autoclavable and can be utilized as a single-use bioreactor system. Scaffold-based 3D Cell Cultures was the second-largest market in 2021, projected to grow at the highest CAGR of 18.88%.

• The rising popularity and awareness of nanotechnology in biomedical research are expected to generate potential growth opportunities for nanofiber-based scaffolds, thereby increasing demand and sales for scaffold-based technology. Magnetic levitational assembly of 3D tissue constructs is a new and rapidly expanding label-free approach to tissue engineering. This is anticipated to propel the scaffold-free segment throughout the projected period.

3D Cell Culture Market, By Application

• Stem Cell Research
• Cancer Research
• Drug Discovery
• Regenerative Medicine

Based on Application, the market is segmented into Stem Cell Research, Cancer Research, Drug Discovery, and Regenerative Medicine. Stem cell research accounted for the largest market share in 2021, and is projected to grow at the highest CAGR of 19.40% during the forecast period. Merck is driven to develop novel cell culture systems and characterization tools for stem cell research and primary cell culture. Merck provides a complete line of stem cell products, such as human and murine stem cells, stem cell and primary cell culture media, growth factors, exclusive antibodies, culture ware, and kits. Cancer Research was the second-largest market in 2021, projected to grow at the highest CAGR of 18.90%.

• It is mainly attributed to the advantages provided by 3D cell culture in cancer research, including the ease of changing cell proliferation and morphology, revealing realistic drug response, capturing phenotypic heterogeneity, enabling experimental manipulation in gene expression and cell behavior, and expressing the tumor microenvironment. Preclinical studies that use the benefits of 3D cell culture can significantly improve awareness of cancer biology. This includes the elimination of ineffective drug candidates as well as the identification of physiologically relevant targets that were previously inaccessible in 2D culture. This can significantly contribute to the segment's growth.

3D Cell Culture Market, By End Users

• Academic Institutes
• Contract Research Laboratories & Diagnostics Centers
• Biotechnology and Pharmaceutical Companies

Based on End Users, the market is segmented into Academic Institutes, Contract Research Laboratories & Diagnostics Centers, and Biotechnology and Pharmaceutical Companies. Contract Research Laboratories & Diagnostics Center accounted for the largest market share in 2021, and is projected to grow at the highest CAGR of 19.24% during the forecast period. These contract research laboratories assist the primary R&D activities, by minimizing the time and resources required to complete the research project.

3D cell culture is the fastest growing segment in the healthcare space due to a wide range of applications in cancer research, in vitro environment, and regenerative medicine. The rise in the adoption of 3D cell culture in diagnostic centers and an increase in demand for organ transplantation and tissue regeneration leads to an increase in the growth of the segment. Biotechnology & Pharmaceutical Companies was the second-largest market in 2021, projected to grow at the highest CAGR of 18.76%.

• In contrast to 2D cell culture, 3D cell culture has a wide range of benefits and advantages in terms of providing appropriate oxygen content and nutritional gradients, as well as aiding in the understanding of various cell functions such as adhesion, proliferation, morphology, viability, microenvironment, and drug response. These are some of the major factors driving the segment's development. The factors include a rising preference for alternative testing models over animal techniques, increased R&D spending in these companies, and the presence of a significant number of pharmaceutical and biotechnology firms.

3D Cell Culture Market, By Geography

• North America
• Europe
• Asia Pacific
• Middle East & Africa
• Latin America
• To Get Summarized Market Report By Geography:-

Based on Geography, the Global 3D Cell Culture Market is classified into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. Middle East and Africa accounted for the largest market share in 2021, and is projected to grow at the highest CAGR of 22.66% during the forecast period. The steadily growing pharmaceutical industry and rising chronic diseases in the region are factors that lead to the increasing adoption of 3D cell culture, as cell culture is a vital function for drug discovery and cancer research which, in turn, helps to push the market growth over the forecast period.

• Asia Pacific was the second-largest market in 2021, projected to grow at the highest CAGR of 20.65%. Cell culture is a crucial and mandatory function for drug discovery, cancer research, and stem cell research. Presently, most of the cells are cultured in 2D, where cells are grown as a single monolayer, instead in 3D cells grow in vivo. Hence growing cancer incidences and expanding pharmaceutical industry are likely to contribute to the growth of the 3D Cell Culture Market in the region.

Key Players

• The "Global 3D Cell Culture Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market include
• Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group Ltd., Corning Incorporated, Sartorius AG, Becton, Dickinson and Company, 3D Biotek LLC, PromoCell GmbH, InSphero AG, Nanofiber Solutions LLC, Synthecon, Inc., Global Cell Solutions, Inc., ReproCELL Inc., QGel SA, Greiner Bio-One International GmbH among others.

Our market analysis offers detailed information on major players wherein our analysts provide insight into the financial statements of all the major players, product portfolio, product benchmarking, and SWOT analysis. The competitive landscape section also includes market share analysis, key development strategies, recent developments, and market ranking analysis of the above-mentioned players globally.

Key Developments

• In August 2021, Amerigo Scientific expanded its cell culture portfolio with the introduction of 3D Cell Culture for scientific applications. This new 3D cell culture system has applications in drug discovery, medicine, nanomaterial evaluation, and basic life science research.
• In January 2021, Jellagen Limited, a biotechnology firm that produces high-value Collagen Type 0 derived from jellyfish, announced the release of its JellaGel Hydrogel, a 3D hydrogel. JellaGel offers customers hydrogel that is non-mammalian, natural, biochemically simple, consistent, and simple to use.
• Ace Matrix Analysis:
• The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as
• Active, Cutting Edge, Emerging, and Innovators.

TABLE OF CONTENTS

1 INTRODUCTION OF THE GLOBAL 3D CELL CULTURE MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Research Timelines
• 1.4 Assumptions
• 1.5 Limitations

2 EXECUTIVE SUMMARY

• 2.1 Ecology mapping
• 2.2 Market Attractiveness Analysis
• 2.3 Absolute Market Opportunity
• 2.4 Geographical Insights
• 2.5 Future Market Opportunities
• 2.6 Global Market Split

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Secondary Research
• 3.3 Primary Research
• 3.4 Subject Matter Expert Advice
• 3.5 Quality Check
• 3.6 Final Review
• 3.7 Data Triangulation
• 3.8 Bottom-Up Approach
• 3.9 Top-Down Approach
• 3.10 Research Flow
• 3.11 Data Sources

4 GLOBAL 3D CELL CULTURE MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Evolution
• 4.3 Market Dynamics
  • 4.3.1 Drivers
  • 4.3.2 Restraints
  • 4.3.3 Opportunities
• 4.4 Porters Five Force Model
• 4.5 Value Chain Analysis
• 4.6 Pricing Analysis

5 GLOBAL 3D CELL CULTURE MARKET, BY TYPE

• 5.1 Overview
• 5.2 3D Bioreactors
• 5.3 Scaffold-Based Platform
• 5.4 Scaffold-Free Platform
• 5.5 Other

6 GLOBAL 3D CELL CULTURE MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Stem Cell Research
• 6.3 Cancer Research
• 6.4 Drug Discovery
• 6.5 Regenerative Medicine

7 GLOBAL 3D CELL CULTURE MARKET, BY END USERS

• 7.1 Overview
• 7.2 Academic Institutes
• 7.3 Contract Research Laboratories & Diagnostics Centers
• 7.4 Biotechnology and Pharmaceutical Companies

8 GLOBAL 3D CELL CULTURE MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Italy
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Argentina
  • 8.5.3 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 UAE
  • 8.6.3 South Africa
  • 8.6.4 Rest of Middle East and Africa

9 GLOBAL 3D CELL CULTURE MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies
• 9.4 Company Industry Footprint
• 9.5 Company Regional Footprint
• 9.6 Ace Matrix

10 COMPANY PROFILES

• 10.1 Thermo Fisher Scientific Inc.
  • 10.1.1 Overview
  • 10.1.2 Company Insights
  • 10.1.3 Business Breakdown
  • 10.1.4 Product Outlook
  • 10.1.5 Key Developments
  • 10.1.6 Winning Imperatives
  • 10.1.7 Current Focus and Strategies
  • 10.1.8 Threat from Competition
  • 10.1.9 Swot Analysis
• 10.2 Merck KGaA
  • 10.2.1 Overview
  • 10.2.2 Company Insights
  • 10.2.3 Business Breakdown
  • 10.2.4 Product Outlook
  • 10.2.5 Key Developments
  • 10.2.6 Winning Imperatives
  • 10.2.7 Current Focus and Strategies
  • 10.2.8 Threat from Competition
  • 10.2.9 Swot Analysis
• 10.3 Lonza Group Ltd.
  • 10.3.1 Overview
  • 10.3.2 Company Insights
  • 10.3.3 Business Breakdown
  • 10.3.4 Product Outlook
  • 10.3.5 Key Developments
  • 10.3.6 Winning Imperatives
  • 10.3.7 Current Focus and Strategies
  • 10.3.8 Threat from Competition
  • 10.3.9 Swot Analysis
• 10.4 Corning Incorporated
  • 10.4.1 Overview
  • 10.4.2 Company Insights
  • 10.4.3 Business Breakdown
  • 10.4.4 Product Outlook
  • 10.4.5 Key Developments
  • 10.4.6 Winning Imperatives
  • 10.4.7 Current Focus and Strategies
  • 10.4.8 Threat from Competition
  • 10.4.9 Swot Analysis
• 10.5 Sartorius AG
  • 10.5.1 Overview
  • 10.5.2 Company Insights
  • 10.5.3 Business Breakdown
  • 10.5.4 Product Outlook
  • 10.5.5 Key Developments
  • 10.5.6 Winning Imperatives
  • 10.5.7 Current Focus and Strategies
  • 10.5.8 Threat from Competition
  • 10.5.9 Swot Analysis
• 10.6 Becton, Dickinson and Company
  • 10.6.1 Overview
  • 10.6.2 Company Insights
  • 10.6.3 Business Breakdown
  • 10.6.4 Product Outlook
  • 10.6.5 Key Developments
  • 10.6.6 Winning Imperatives
  • 10.6.7 Current Focus and Strategies
  • 10.6.8 Threat from Competition
  • 10.6.9 Swot Analysis
• 10.7 3D Biotek LLC
  • 10.7.1 Overview
  • 10.7.2 Company Insights
  • 10.7.3 Business Breakdown
  • 10.7.4 Product Outlook
  • 10.7.5 Key Developments
  • 10.7.6 Winning Imperatives
  • 10.7.7 Current Focus and Strategies
  • 10.7.8 Threat from Competition
  • 10.7.9 Swot Analysis
• 10.8 PromoCell GmbH
  • 10.8.1 Overview
  • 10.8.2 Company Insights
  • 10.8.3 Business Breakdown
  • 10.8.4 Product Outlook
  • 10.8.5 Key Developments
  • 10.8.6 Winning Imperatives
  • 10.8.7 Current Focus and Strategies
  • 10.8.8 Threat from Competition
  • 10.8.9 Swot Analysis
• 10.9 InSphero AG
  • 10.9.1 Overview
  • 10.9.2 Company Insights
  • 10.9.3 Business Breakdown
  • 10.9.4 Product Outlook
  • 10.9.5 Key Developments
  • 10.9.6 Winning Imperatives
  • 10.9.7 Current Focus and Strategies
  • 10.9.8 Threat from Competition
  • 10.9.9 Swot Analysis
• 10.10 Nanofiber Solutions LLC
  • 10.10.1 Overview
  • 10.10.2 Company Insights
  • 10.10.3 Business Breakdown
  • 10.10.4 Product Outlook
  • 10.10.5 Key Developments
  • 10.10.6 Winning Imperatives
  • 10.10.7 Current Focus and Strategies
  • 10.10.8 Threat from Competition
  • 10.10.9 Swot Analysis

11 KEY DEVELOPMENTS

• 11.1 Product Launches/Developments
• 11.2 Mergers and Acquisitions
• 11.3 Business Expansions
• 11.4 Partnerships and Collaborations

12 Appendix

• 12.1.1 Related Research